Nobilis IB + ND + EDS
Active substance
ATC code
Species
Chickens (breeders and layers).
Indications
The vaccine is recommended for the vaccination of laying and breeding birds to:
- Prevent egg production losses caused by infection with the Massachusetts serotype of avian infectious bronchitis virus (IBV), and reduce infection in primed birds.
- Prevent mortality and clinical signs and reduction of infection caused by Newcastle disease virus (NDV).
- Prevent egg production losses and egg quality defects caused by infection with egg drop syndrome ’76 virus (EDSV).
Onset of immunity: Active immunity develops within 4 weeks.
Duration of immunity: One laying period (for avian infectious bronchitis and Newcastle disease viruses, this requires birds to have been adequately primed with live vaccines against these pathogens during the growing phase).
Dose to be administered and administration route
Dose: 0.5 ml per bird.
Routes of administration: Intramuscular injection in the thigh or chest muscle, or by subcutaneous injection in the back of the neck, using a medium sized needle (20 G x ½”).
Nobilis IB+ND+EDS should be given to birds around 14–20 weeks of age but not less than 4 weeks before the expected onset of lay.
Priming with live vaccines for avian infectious bronchitis and Newcastle disease viruses is necessary unless serological tests indicate otherwise. The interval between priming and booster should not be less than 4 weeks and preferably more than 6 weeks.
Allow the vaccine to reach ambient temperature (15–25 °C) before use.
The vaccine may occasionally separate into two layers on storage. This in no way affects its potency. Shake the bottle vigorously before and periodically during use.
An automatic injection system, incorporating a means to prevent back-flushing and hence possible contamination of the vaccine, should be used for administration.
Ensure that vaccination equipment is clean and sterile before use. Do not use vaccination equipment with rubber parts as the excipient may attack certain types of rubber.
Adverse reactions
A mild transient swelling may be observed at the injection site for 2 weeks.
TRUSTED SOURCE
